Chemfab Alka.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE783X01023
  • NSEID: CHEMFAB
  • BSEID: 541269
INR
375.00
-18.2 (-4.63%)
BSENSE

Jun 12, 03:30 PM

BSE+NSE Vol: 2.14 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.14 k (47.64%) Volume

Shareholding (Mar 2026)

FII

0.04%

Held by 2 FIIs

DII

0.17%

Held by 0 DIIs

Promoter

72.13%

Why is Chemfab Alkalis Ltd falling/rising?

12-Jun-2026

As of 11-Jun, Chemfab Alkalis Ltd's stock is at 393.20, down 4.25%, with a significant decline of 50.20% over the past year. The company faces financial challenges, including negative operating profits for 12 quarters and a high debt-to-equity ratio, leading to a negative market sentiment despite increased investor participation.

As of 11-Jun, Chemfab Alkalis Ltd's stock price is falling, currently at 393.20, reflecting a decrease of 17.45 (-4.25%). The stock has been underperforming significantly, with a consecutive decline over the last two days resulting in an overall drop of 8.83%. Today, it opened with a loss of 4.99% and reached an intraday low of Rs 390.15. <BR><BR>In the past week, the stock has decreased by 3.86%, and over the last month, it has fallen by 12.06%. Year-to-date, the stock is down 4.68%, and it has experienced a staggering decline of 50.20% over the past year, which is substantially worse than the broader market's decline of 10.52% during the same period. <BR><BR>The company's financial health is concerning, as it has reported negative operating profits for the last 12 consecutive quarters, with an annual operating profit growth rate of -182.98% over the last five years. Additionally, the stock's performance is compounded by a negative EBIT of Rs. -1.2 cr and a significant profit decline of -216.3% over the past year. <BR><BR>Despite a rise in investor participation, with delivery volume increasing by 539.34% against the five-day average, the overall sentiment remains negative due to the company's poor long-term growth prospects and high debt-to-equity ratio, which has reached 0.34 times in the latest half-year. This combination of factors contributes to the stock's ongoing decline.

View full answer

What does Chemfab Alka. do?

11-Jun-2026

Chemfab Alkalis Ltd manufactures caustic soda, liquid chlorine, hydrogen gas, and PVCO pipes, operating in the commodity chemicals sector. Incorporated in 2009, it has a market cap of INR 584 Cr and reported net sales of 75 Cr with no profit for the quarter ending March 2026.

Overview:<BR>Chemfab Alkalis Ltd is a manufacturer of caustic soda lye, flakes, liquid chlorine, hydrogen gas, PVCO pipes, and other products in the commodity chemicals industry, categorized as a micro-cap company.<BR><BR>History:<BR>Chemfab Alkalis Ltd was incorporated on May 6, 2009, and was formerly known as Teamec Chlorates Limited. The company changed its name on July 21, 2017, following a scheme of amalgamation dated March 30, 2017. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 75 Cr (Quarterly Results - Mar 2026)<BR>Net Profit: 0 Cr (Quarterly Results - Mar 2026)<BR>Market Cap: INR 584 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A<BR>Industry P/E: 42<BR>Dividend Yield: 0.28%<BR>Debt Equity: 0.30<BR>Return on Equity: -0.91%<BR>Price to Book: 1.64<BR><BR>Contact Details:<BR>Address: Team House, GST Salai Vandalur Chennai Tamil Nadu : 600048<BR>Tel: 91-44-22750323/24<BR>Email: chemfabalkalis@drraholdings.com<BR>Website: http://www.chemfabalkalis.com

View full answer

How big is Chemfab Alka.?

11-Jun-2026

As of 10th June, Chemfab Alkalis Ltd has a market capitalization of 584.00 Cr and reported Net Sales of 311.02 Cr, with a Net Profit loss of 3.43 Cr over the latest 4 quarters. Shareholder's Funds are 379.99 Cr and Total Assets are 498.84 Cr as of March 2025.

As of 10th June, Chemfab Alkalis Ltd has a market capitalization of 584.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest 4 quarters, Chemfab Alkalis Ltd reported Net Sales of 311.02 Cr. However, the company experienced a loss of 3.43 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2025. Shareholder's Funds are reported at 379.99 Cr, while Total Assets stand at 498.84 Cr.

View full answer

Who are in the management team of Chemfab Alka.?

11-Jun-2026

The management team of Chemfab Alka includes Suresh Krishnamurthi Rao (Chairman), C S Ramesh, R Mahendran, Nitin S Cowlagi (all Non-Executive & Non-Independent Directors), and independent directors Sujatha Jayarajan, Drushti Desai, A Janakiraman, and T Ramabadran.

The management team of Chemfab Alka includes the following members:<BR><BR>1. **Suresh Krishnamurthi Rao** - Chairman (Non-Executive) & Director (Non-Independent)<BR>2. **C S Ramesh** - Non-Executive & Non-Independent Director<BR>3. **R Mahendran** - Non-Executive & Non-Independent Director<BR>4. **Sujatha Jayarajan** - Independent Director<BR>5. **Drushti Desai** - Independent Director<BR>6. **A Janakiraman** - Independent Director<BR>7. **T Ramabadran** - Independent Director<BR>8. **Nitin S Cowlagi** - Non-Executive & Non-Independent Director<BR><BR>If you have any more questions about Chemfab Alka or its operations, feel free to ask!

View full answer

Who are the peers of the Chemfab Alka.?

11-Jun-2026

Chemfab Alka's peers include OCCL, Tuticorin Alkali, and Vikram Thermo, among others. OCCL shows excellent management and growth, while Chemfab Alka has below-average growth and a 1-year return of -50.09%.

Peers: The peers of Chemfab Alka. are Sr.Rayala.Hypo, Blue Pearl Agri, Sadhana Nitro, Tuticorin Alkali, OCCL, Primo Chemicals, Vikram Thermo, Transpek Inds., POCL Enterprises, and Andhra Petrochem.<BR><BR>Quality Snapshot: Excellent management risk is observed at OCCL, Tuticorin Alkali, and Vikram Thermo, while Average management risk is found at Chemfab Alka., Sr.Rayala.Hypo, Blue Pearl Agri, Sadhana Nitro, Primo Chemicals, Transpek Inds., POCL Enterprises, and Andhra Petrochem. Below Average management risk is noted at OCCL. In terms of Growth, Excellent growth is seen at OCCL and POCL Enterprises, Good growth at Tuticorin Alkali, Average growth at Blue Pearl Agri, while Below Average growth is found at Chemfab Alka., Sadhana Nitro, Primo Chemicals, Vikram Thermo, and Andhra Petrochem. Capital Structure is Excellent for Chemfab Alka., OCCL, and Tuticorin Alkali, Good for Blue Pearl Agri and Transpek Inds., Average for Primo Chemicals, and Below Average for Sadhana Nitro and POCL Enterprises.<BR><BR>Return Snapshot: The peer with the highest 1-year return is OCCL at 8.60%, while the peer with the lowest is Sadhana Nitro at -86.72%. Chemfab Alka.'s own 1-year return is -50.09%, which is significantly higher than Sadhana Nitro's. Additionally, the six-month return is negative for Chemfab Alka., Sadhana Nitro, Blue Pearl Agri, Transpek Inds., and POCL Enterprises.

View full answer

Are Chemfab Alkalis Ltd latest results good or bad?

15-May-2026

Chemfab Alkalis Ltd's latest results show a return to profitability with a net profit of ₹0.48 crore in Q4 FY26 and a 9.74% increase in net sales quarter-on-quarter. However, year-on-year sales declined by 19%, and operating margins contracted, indicating ongoing challenges in the commodity chemicals sector.

Chemfab Alkalis Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹0.48 crore in Q4 FY26, marking a return to profitability after several quarters of losses, which is a positive development. Additionally, net sales increased by 9.74% quarter-on-quarter, indicating some sequential improvement.<BR><BR>However, the year-on-year comparison reveals significant challenges. Net sales declined by 19% compared to the same quarter last year, and the operating margin has also contracted, falling to 11.39% from higher levels in the previous year. This suggests ongoing structural issues and pricing pressures in the commodity chemicals sector.<BR><BR>Moreover, the company’s reliance on other income for profitability raises concerns about the sustainability of this turnaround. The quality of earnings is questionable, as other income accounted for a substantial portion of profit before tax.<BR><BR>Overall, while there are signs of improvement in the most recent quarter, the broader trends indicate that Chemfab Alkalis is still grappling with significant operational challenges and margin erosion. Investors should approach the situation with caution, considering both the recent positive developments and the underlying issues that persist.

View full answer

Should I buy, sell or hold Chemfab Alkalis Ltd?

15-May-2026

How has been the historical performance of Chemfab Alka.?

31-Oct-2025

Chemfab Alka's historical performance shows increasing net sales and total assets, but declining profitability, with a profit after tax of -INR 6.94 crore in March 2025, following a peak in March 2023. Total expenditures rose significantly, impacting operating profit and leading to negative profit before tax in 2025.

Answer:<BR>The historical performance of Chemfab Alka shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Chemfab Alka's net sales have seen a gradual increase from INR 204.52 crore in March 2020 to INR 334.37 crore in March 2025, with a slight dip in March 2023. Total operating income followed a similar pattern, reaching INR 334.37 crore in March 2025. However, the total expenditure has also risen significantly, from INR 149.48 crore in March 2020 to INR 290.65 crore in March 2025. This led to a decline in operating profit, which peaked at INR 115.99 crore in March 2023 but fell to INR 50.84 crore in March 2025. The profit before tax turned negative in March 2025 at INR -0.31 crore, following a positive trend in previous years. Consequently, the profit after tax also dropped to INR -6.94 crore in March 2025, contrasting with INR 64.58 crore in March 2023. The company's total assets increased from INR 296.50 crore in March 2020 to INR 498.84 crore in March 2025, while total liabilities also rose from INR 296.50 crore to INR 498.84 crore during the same period. Cash flow from operating activities improved to INR 39 crore in March 2025, although cash flow from investing activities remained negative at INR -85 crore. Overall, Chemfab Alka's financial performance reflects both growth in sales and assets, but challenges in profitability and increasing costs.

View full answer

Is Chemfab Alka. technically bullish or bearish?

04-Aug-2025

As of August 1, 2025, Chemfab Alka's trend has shifted to a moderate bearish stance, indicated by bearish MACD and Bollinger Bands, despite mixed signals from the KST.

As of 1 August 2025, the technical trend for Chemfab Alka has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include a bearish MACD on the weekly chart, bearish signals from Bollinger Bands on both weekly and monthly time frames, and a bearish moving average on the daily chart. The KST shows a mildly bullish signal on the weekly but is mildly bearish monthly, indicating mixed signals in the short term. Overall, the prevailing bearish sentiment is supported by the recent price action, with the stock down significantly year-to-date and over the past month.

View full answer

When is the next results date for Chemfab Alka.?

28-Jul-2025

Chemfab Alka is scheduled to declare its results on July 31, 2025.

Chemfab Alka is scheduled to declare its results on 31 July 2025.

View full answer

Who are the top shareholders of the Chemfab Alka.?

17-Jul-2025

The top shareholder of Chemfab Alka is Dr Rao Holdings Pte Ltd, with a 47.07% stake. V. M. Srinivasan is the largest individual shareholder at 1.81%, while individual investors hold 21.53% of the shares.

The top shareholders of Chemfab Alka include Dr Rao Holdings Pte Ltd, which holds the largest stake at 47.07%. The company is primarily owned by its promoters, with no pledged promoter holdings reported. In terms of public shareholders, V. M. Srinivasan is the highest individual shareholder, owning 1.81%. Additionally, individual investors collectively hold 21.53% of the shares, while mutual funds and foreign institutional investors hold minor stakes of 0.07% and 0.03%, respectively.

View full answer

Is Chemfab Alka. overvalued or undervalued?

09-Jun-2025

As of May 23, 2024, Chemfab Alkalis Ltd. is considered very expensive and overvalued, with a PE ratio of 367.03 and significant underperformance against the Sensex, indicating a lack of growth expectations and high valuation compared to industry benchmarks.

As of 23 May 2024, the valuation grade for Chemfab Alkalis Ltd. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued. Key ratios highlight this concern, with a PE ratio of 367.03, an EV to EBIT of 155.27, and a Price to Book Value of 2.85, all of which are substantially higher than typical industry benchmarks.<BR><BR>In comparison to peers, Chemfab Alkalis Ltd. stands out with a PE ratio significantly above the average, while its EV to EBITDA ratio of 26.21 aligns with its high valuation. Notably, the company has a PEG ratio of 0.00, suggesting no growth expectations are priced in, which further emphasizes its overvaluation. Recent performance shows that Chemfab has underperformed against the Sensex, with a year-to-date return of -26.8% compared to the Sensex's 5.56%, reinforcing the notion that the stock may be overvalued in the current market context.

View full answer

Has Chemfab Alka. declared dividend?

06-Jun-2025

Yes, Chemfab Alkalis Ltd has declared a 12% dividend, amounting to ₹1.2 per share, with an ex-date of September 13, 2024. Despite recent fluctuations, the company has shown strong long-term total returns, particularly over the 3 to 5 year periods.

Chemfab Alkalis Ltd has declared a 12% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 12%<BR>- Amount per share: 1.2<BR>- Ex-date: 13 Sep 24<BR><BR>Dividend Yield: 0.16%.<BR><BR>Total Returns by Period:<BR>In the 6 months period, the price return was -31.68%, with a dividend return of 0%, resulting in a total return of -31.68%.<BR><BR>For the 1 year period, the price return was 33.47%, the dividend return was 0.19%, leading to a total return of 33.66%.<BR><BR>Over the 2 years period, the price return was 130.2%, with a dividend return of 0.74%, culminating in a total return of 130.94%.<BR><BR>In the 3 years period, the price return was 354.78%, the dividend return was 2.32%, resulting in a total return of 357.1%.<BR><BR>For the 4 years period, the price return was 413.05%, with a dividend return of 2.46%, leading to a total return of 415.51%.<BR><BR>In the 5 years period, the price return was 440.62%, with a dividend return of 3.57%, resulting in a total return of 444.19%.<BR><BR>Overall, Chemfab Alkalis Ltd has declared a dividend, and while the recent returns show significant fluctuations, the long-term performance indicates a strong upward trend in total returns, particularly over the 3 to 5 year periods.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate -182.98% of over the last 5 years

 
2

The company has declared Negative results for the last 12 consecutive quarters

3

Risky - Negative Operating Profits

4

Despite the size of the company, domestic mutual funds hold only 0.25% of the company

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 571 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

0.31%

stock-summary
Debt Equity

0.30

stock-summary
Return on Equity

-0.91%

stock-summary
Price to Book

1.49

Revenue and Profits:
Net Sales:
75 Cr
(Quarterly Results - Mar 2026)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.31%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.32%
0%
-0.32%
6 Months
-19.19%
0%
-19.19%
1 Year
-52.59%
0.16%
-52.43%
2 Years
-46.04%
0.38%
-45.66%
3 Years
14.16%
1.15%
15.31%
4 Years
113.61%
2.95%
116.56%
5 Years
150.0%
3.00%
153.0%

Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Jun-2026 | Source : BSE

Submission of copy of newspaper publication wrt. SEBI circular dated 30th Jan 2026 on special window for transfer and dematerialisation of physical securities.

Compliances-Reg.24(A)-Annual Secretarial Compliance

26-May-2026 | Source : BSE

Dear Sir/Mam Please find enclosed Annual Secretarial Compliance Report for the financial Year ended 31st March 2026

Announcement under Regulation 30 (LODR)-Acquisition

20-May-2026 | Source : BSE

Submission of Letter dated 20th May 2026 regarding investment by the Company in Zenataris Renewable Energy Private Limited. Kindly take the same on record.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
11.46%
EBIT Growth (5y)
-182.98%
EBIT to Interest (avg)
30.90
Debt to EBITDA (avg)
1.27
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
0.79
Tax Ratio
100.00%
Dividend Payout Ratio
-25.87%
Pledged Shares
0
Institutional Holding
0.21%
ROCE (avg)
10.51%
ROE (avg)
7.16%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
41
Price to Book Value
1.44
EV to EBIT
-541.98
EV to EBITDA
23.89
EV to Capital Employed
1.34
EV to Sales
2.09
PEG Ratio
NA
Dividend Yield
0.32%
ROCE (Latest)
-0.25%
ROE (Latest)
-0.91%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.07%)

FIIs

Held by 2 FIIs (0.04%)

Promoter with highest holding

Dr Rao Holdings Pte Ltd (47.04%)

Highest Public shareholder

V. M. Srinivasan (1.8%)

Individual Investors Holdings

21.63%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 9.74% vs -11.00% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 110.79% vs -121.39% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.78",
          "val2": "68.14",
          "chgp": "9.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.52",
          "val2": "1.94",
          "chgp": "339.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.14",
          "val2": "2.03",
          "chgp": "5.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.48",
          "val2": "-4.45",
          "chgp": "110.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.39%",
          "val2": "2.85%",
          "chgp": "8.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.10",
          "val2": "158.43",
          "chgp": "6.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.76",
          "val2": "18.48",
          "chgp": "-9.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.51",
          "val2": "2.16",
          "chgp": "62.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.54",
          "val2": "0.36",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.97%",
          "val2": "11.66%",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "236.24",
          "val2": "242.05",
          "chgp": "-2.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18.70",
          "val2": "30.39",
          "chgp": "-38.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.54",
          "val2": "3.36",
          "chgp": "64.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.91",
          "val2": "2.24",
          "chgp": "-274.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.92%",
          "val2": "12.56%",
          "chgp": "-4.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "311.02",
          "val2": "334.37",
          "chgp": "-6.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.22",
          "val2": "43.72",
          "chgp": "-37.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.69",
          "val2": "4.93",
          "chgp": "55.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-9.89",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.43",
          "val2": "-6.94",
          "chgp": "50.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.75%",
          "val2": "13.08%",
          "chgp": "-4.33%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
74.78
68.14
9.74%
Operating Profit (PBDIT) excl Other Income
8.52
1.94
339.18%
Interest
2.14
2.03
5.42%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.48
-4.45
110.79%
Operating Profit Margin (Excl OI)
11.39%
2.85%
8.54%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 9.74% vs -11.00% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 110.79% vs -121.39% in Dec 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
168.10
158.43
6.10%
Operating Profit (PBDIT) excl Other Income
16.76
18.48
-9.31%
Interest
3.51
2.16
62.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.54
0.36
50.00%
Operating Profit Margin (Excl OI)
9.97%
11.66%
-1.69%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
236.24
242.05
-2.40%
Operating Profit (PBDIT) excl Other Income
18.70
30.39
-38.47%
Interest
5.54
3.36
64.88%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.91
2.24
-274.55%
Operating Profit Margin (Excl OI)
7.92%
12.56%
-4.64%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
311.02
334.37
-6.98%
Operating Profit (PBDIT) excl Other Income
27.22
43.72
-37.74%
Interest
7.69
4.93
55.98%
Exceptional Items
0.00
-9.89
100.00%
Consolidate Net Profit
-3.43
-6.94
50.58%
Operating Profit Margin (Excl OI)
8.75%
13.08%
-4.33%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025

stock-summaryCompany CV
About Chemfab Alkalis Ltd stock-summary
stock-summary
Chemfab Alkalis Ltd
Micro Cap
Commodity Chemicals
Chemfab Alkalis Limited, formerly known as Teamec Chlorates Limited was incorporated on 06 May, 2009. The name of the Company was changed from Teamec Chlorates Limited to Chemfab Alkalis Limited on July 21, 2017, vide Revised Certi?cate of Incorporation issued by the Registrar of Companies pursuant to the Scheme of Amalgamation dated 30 March 2017. The Company is a manufacturer of caustic soda lye, ?akes, liquid chlorine, hydrogen gas, PVCO Pipes and other products.
Company Coordinates stock-summary
Company Details
Team House, GST Salai Vandalur Chennai Tamil Nadu : 600048
stock-summary
Tel: 91-44-22750323/24
stock-summary
chemfabalkalis@drraholdings.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai